CELLDEX THERAPEUTICS INC NEW's ticker is and the CUSIP is 15117B953. A total of 3 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $373,000 | +48.6% | 238 | 0.0% | 0.02% | +110.0% |
| Q3 2015 | $251,000 | -94.4% | 238 | -86.5% | 0.01% | -93.8% |
| Q2 2015 | $4,444,000 | +3.1% | 1,762 | +13.9% | 0.16% | -9.5% |
| Q1 2015 | $4,311,000 | +158.8% | 1,547 | +124.9% | 0.18% | +68.9% |
| Q4 2013 | $1,666,000 | -58.7% | 688 | -39.5% | 0.11% | -59.5% |
| Q3 2013 | $4,032,000 | – | 1,138 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 1 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 33,700 | $17,000 | 0.00% |